The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years?
Open accessAbstract
Our understanding of the microbial involvement in inflammatory bowel disease (IBD) pathogenesis has increased exponentially over the past decade. The development of newer molecular tools for the global assessment of the gut microbiome and the identification of nucleotide-binding oligomerization domain-containing protein 2 in 2001 and other susceptibility genes for Crohn's disease in particular has led to better understanding of the aetiopathogenesis of IBD. The microbial studies have elaborated the normal composition of the gut microbiome and its perturbations in the setting of IBD. This altered microbiome or "dysbiosis" is a key player in the protracted course of inflammation in IBD. Numerous genome-wide association studies have identified further genes involved in gastrointestinal innate immunity (including polymorphisms in genes involved in autophagy: ATG16L1 and IGRM), which have helped elucidate the relationship of the local innate immunity with the adjacent luminal bacteria. These developments have also spurred the search for specific pathogens which may have a role in the metamorphosis of the gut microbiome from a symbiotic entity to a putative pathogenic one. Here we review advances in our understanding of microbial involvement in IBD pathogenesis over the past 10 years and offer insight into how this will shape our therapeutic management of the disease in the coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, alteration of the intestinal microbiota has been demonstrated to be a key player in the protracted course of inflammation in inflammatory bowel diseases (IBD) [22].”
From Intestinal Microbiota Is Influenced by Gender and Body Mass Index (2016) · cites this paper as [22]
In the citing paper
“A definitive change of the normal gut microbiota with a breakdown of host-microbial mutualism is probably the defining event in IBD development.59”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–236 of 236
Clancy, R. L., Ren, Z., Turton, J., Pang, G., & Wettstein, A. R. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.12.006 · Cited by 49
Detection of Helicobacteraceae in Intestinal Biopsies of Children with Crohn’s Disease
Kaakoush, N. O., Holmes, J., Octavia, S., Man, S. M., Zhang, L., Castaño‐Rodríguez, N., Day, A. S., Leach, S. T., Lemberg, D. A., Dutt, S., et al. (2010) · Helicobacter · doi:10.1111/j.1523-5378.2010.00792.x · Cited by 47
Golan, L., Livneh-Kol, A., Gonen, E., Yagel, S., Rosenshine, I., & Shpigel, N. Y. (2009) · The Journal of Infectious Diseases · doi:10.1086/596033 · Cited by 46
Absence of mycobacterium avium subsp. paratuberculosis in Crohnʼs patients
Parrish, N. M., Radcliff, R. P., Brey, B. J., Anderson, J. L., Clark, D. L., Koziczkowski, J. J., Ko, C. G., Goldberg, N. D., Brinker, D. A., Carlson, R. A., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20799 · Cited by 44
Zhang, L., Danon, S. J., Grehan, M., Chan, V., Lee, A. C., & Mitchell, H. M. (2005) · Helicobacter · doi:10.1111/j.1523-5378.2005.00314.x · Cited by 40
Whary, M. T., Danon, S. J., Feng, Y., Ge, Z., Sundina, N., Ng, V., Taylor, N. S., Rogers, A. B., & Fox, J. G. (2006) · Infection and Immunity · doi:10.1128/iai.01091-06 · Cited by 40
Helicobacter Species in the Intestinal Mucosa of Patients with Ulcerative Colitis
de Oliveira, A. G., Sanna, M. D. G. P., Rocha, G. A., Rocha, A. M. C., Santos, A., Dani, R., Marinho, F. P., Moreira, L. S., Ferrari, M. D. L. A., Moura, S. B., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.384-386.2004 · Cited by 40
Evaluation of Helicobacter species in inflammatory bowel disease
Bell, S., Chisholm, S., Owen, R. J., Borriello, S. P., & Kamm, M. A. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01703.x · Cited by 39
Ewaschuk, J. B., Tejpar, Q., Soo, I., Madsen, K. L., & Fedorak, R. N. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0039-z · Cited by 39
Probiotics for induction of remission in ulcerative colitis
Mallon, P. W. G., McKay, D., Kirk, S. J., & Gardiner, K. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005573 · Cited by 39
Bernstein, C. N., Wang, M., Sargent, M. J., Brant, S. R., & Collins, M. T. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02062-06 · Cited by 34
Lee, A., Griffiths, T. A. M., Parab, R. S., King, R. K., Dubinsky, M. C., Urbanski, S. J., Wrobel, I. T., & Rioux, K. P. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181ef37ba · Cited by 31
Pathogenic Potential of Campylobacter ureolyticus
Burgos-Portugal, J. A., Kaakoush, N. O., Raftery, M. J., & Mitchell, H. M. (2011) · Infection and Immunity · doi:10.1128/iai.06031-11 · Cited by 31
Immunoreactive proteins ofCampylobacter concisus, an emergent intestinal pathogen
Kovách, Z., Kaakoush, N. O., Lamb, S., Zhang, L., Raftery, M. J., & Mitchell, H. M. (2011) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2011.00864.x · Cited by 30
Role of Helicobacter Species in Chinese Patients with Inflammatory Bowel Disease
Zhang, S., Zhong, B., Chao, K., Xiao, Y., Cui, Y., Gao, X., Chen, B., He, Y., Hu, P., Chen, M., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02630-10 · Cited by 30
Streutker, C., Bernstein, C. N., Chan, V., Riddell, R. H., & Croitoru, K. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.660-664.2004 · Cited by 28
Crohn's disease: the case for bacteria.
Prantera, C., & Scribano, M. L. (1999) · PubMed · Cited by 27
Characterization ofCampylobacter concisushemolysins
Istivan, T. S., Smith, S. C., Fry, B. N., & Coloe, P. J. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00467.x · Cited by 27
Liu, Z., Ramer‐Tait, A. E., Henderson, A. L., Demirkale, C. Y., Nettleton, D. S., Wang, C., Hostetter, J. M., Jergens, A. E., & Wannemuehler, M. J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1701-3 · Cited by 26
NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease.
Glubb, D. M., Gearry, R. B., Barclay, M. L., Roberts, R. L., Pearson, J. F., Keenan, J. I., McKenzie, J., & Bentley, R. W. (2011) · PubMed Central · doi:10.3748/wjg.v17.i23.2829 · Cited by 25
Huijsdens, X. W., Linskens, R. K., Koppes, J., Tang, Y. L., Meuwissen, S. G. M., Vandenbroucke‐Grauls, C. M. J. E., & Savelkoul, P. H. M. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.01.007 · Cited by 25
Fiocchi, C. (2012) · Digestive Diseases · doi:10.1159/000342585 · Cited by 24
Seroprevalence ofFusobacterium variumin ulcerative colitis patients in Japan
Minami, M., Ando, T., Okamoto, A., Sasaki, N., Ohkura, T., Torii, K., Hasegawa, T., Ohta, M., & Goto, H. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00550.x · Cited by 22
Role of genetics in the diagnosis and prognosis of Crohn's disease
Tsianos, E. V. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i48.5246 · Cited by 22
Crohn’s as an immune deficiency: from apparent paradox to evolving paradigm
Vinh, D. C., & Behr, M. A. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.87 · Cited by 21
Sasikala, M., Reddy, D. N., Pratap, N., Sharma, S. K., Reddy, P. B., Sekaran, A., Banerjee, R., & Reddy, D. B. (2009) · Indian Journal of Gastroenterology · doi:10.1007/s12664-009-0068-2 · Cited by 21
Nakase, H., Tamaki, H., Matsuura, M., Chiba, T., & Okazaki, K. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21750 · Cited by 20
Neutrophil activation by Campylobacter concisus
Sørensen, N. B., Nielsen, H. L., Varming, K., & Nielsen, H. I. (2013) · Gut Pathogens · doi:10.1186/1757-4749-5-17 · Cited by 20
Cantó, E. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i41.5446 · Cited by 19
Momotani, E., Ozaki, H., Hori, M., Yamamoto, S., Kuribayashi, T., Eda, S., & Ikegami, M. (2012) · SpringerPlus · doi:10.1186/2193-1801-1-47 · Cited by 19
The role of antimicrobials in Crohn’s disease
Kale-Pradhan, P. B., Zhao, J., Palmer, J. R., & Wilhelm, S. M. (2013) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.13.6 · Cited by 14
New insights into the immunopathology of chronic inflammatory bowel disease.
Ro, E. (1996) · PubMed · Cited by 13
PathogenicYersiniaDNA in Intestinal Specimens of Pediatric Patients with Crohn's Disease
Leu, S. B., Shulman, S. C., Steelman, C. K., Lamps, L. W., Bulut, O. P., Abramowsky, C. R., Gold, B. D., Szlam, S. M., Stockwell, C. A., Havens, J. M., et al. (2013) · Fetal and Pediatric Pathology · doi:10.3109/15513815.2013.768744 · Cited by 11
Tamboli, C., Good, M. R., Reynolds, E. M., Sharma, P., & Mitros, F. A. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.627450 · Cited by 7
Keenan, J. I., Mitchell, H. M., & Day, A. S. (2011) · PubMed · Cited by 7
Elisabet, Елена, Ricart, David, D., Busquets, Monfort, Esther, García-Planella, Dolors, González, et al. (2007) · World Journal of Gastroenterology · Cited by 4
Flagged first, then by citations
Research works printed but not linked: 2
- Istivan TS, Smith SC, Fry BN, Coloe PJ. Characterization of Campylobacter concisus hemolysins. FEMS Immunol Med Microbiol 2008; 54: 224-235 [PMID: 18754784 DOI: 10.1111/ j.1574-695X.2008.00467.x] 151 · DOI
- Simpson KW, Dogan B, Rishniw M, Goldstein RE, Klaes- sig S, McDonough PL, German AJ, Yates RM, Russell DG, Johnson SE, Berg DE, Harel J, Bruant G, McDonough SP, Schukken YH. Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun 2006; 74: 4778-4792 [PMID: 16861666 DOI: 10.1128/ IAI.00067-06] 153 · DOI
Cited by
Sorted by citations
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
Self-citationTherapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
Gao, J., Xu, K., Liu, H., Liu, G., Bai, M., Peng, C., Li, T., & Yin, Y. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00013 · Cited by 1,357
Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C. (2019) · Pathogens · doi:10.3390/pathogens8030126 · Cited by 771
Metadata
- Authors
- Hold, G. L.
- Affiliations
- University of Aberdeen (GB)
- Corresponding author
- Hold, Georgina L
- ORCID
- Hold, Georgina L
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 5
- Pages
- 1192
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC3921503
- OpenAlex
- W2115524426
- Cited by
- 365
- References
- 235
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 27 · 2023: 25 · 2022: 24 · 2021: 40 · 2020: 27 · 2019: 41 · 2018: 36 · 2017: 31 · 2016: 31 · 2015: 34 · 2014: 11
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- gut microbiota, inflammatory bowel disease, Crohn's disease, dysbiosis, NOD2, susceptibility genes, innate immunity, autophagy, ATG16L1, pathogen identification
- MeSH terms
- Animals, Bacteria, Colitis, Ulcerative, Crohn Disease, Humans, Immunity, Innate, Intestines, Phenotype, Risk Factors, Immunity, Mucosal, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Microbiota, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
